Study: NCT01369147

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Parenteral Nutrition
Description: The PN dose will be written for each 24-hr period taking into account any kilocalories (kcal) provided as part of standard of care from propofol, clevidipine, dextrose-containing IV fluid exceeding 500 mL/day, and enteral feedings.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Parenteral Nutrition
Description: The PN dose will be written for each 24-hr period taking into account any kilocalories (kcal) provided as part of standard of care from propofol, clevidipine, dextrose-containing IV fluid exceeding 500 mL/day, and enteral feedings.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Parenteral Nutrition
Description: The PN dose will be written for each 24-hr period taking into account any kilocalories (kcal) provided as part of standard of care from propofol, clevidipine, dextrose-containing IV fluid exceeding 500 mL/day, and enteral feedings.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: The PN dose will be written for each 24-hr period taking into account calories provided as lipid emulsion in the sedative propofol (1.1 kcal/mL).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Propofol
Description: The PN dose will be written for each 24-hr period taking into account calories provided as lipid emulsion in the sedative propofol (1.1 kcal/mL).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Propofol
Description: The PN dose will be written for each 24-hr period taking into account calories provided as lipid emulsion in the sedative propofol (1.1 kcal/mL).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clevidipine
Description: The PN dose will be written for each 24-hr period taking into account calories provided as lipid emulsion in clevidipine (2 kcal/mL).

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Clevidipine
Description: The PN dose will be written for each 24-hr period taking into account calories provided as lipid emulsion in clevidipine (2 kcal/mL).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Clevidipine
Description: The PN dose will be written for each 24-hr period taking into account calories provided as lipid emulsion in clevidipine (2 kcal/mL).

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextrose-containing IV Fluids
Description: The PN dose will be written for each 24-hr period taking into account calories provided from dextrose-containing IV fluid orders exceeding 500 mL/day.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Dextrose-containing IV Fluids
Description: The PN dose will be written for each 24-hr period taking into account calories provided from dextrose-containing IV fluid orders exceeding 500 mL/day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dextrose-containing IV Fluids
Description: The PN dose will be written for each 24-hr period taking into account calories provided from dextrose-containing IV fluid orders exceeding 500 mL/day.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enteral feeding
Description: Enteral nutrition is caloric intake through the gastrointestinal (GI) tract via food consumed through the mouth or a feeding tube delivering nutrition directly to the stomach or small intestines. The PN dose will be written for each 24-hr period taking into account calories provided from any enteral feedings.

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enteral feeding
Description: Enteral nutrition is caloric intake through the gastrointestinal (GI) tract via food consumed through the mouth or a feeding tube delivering nutrition directly to the stomach or small intestines. The PN dose will be written for each 24-hr period taking into account calories provided from any enteral feedings.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enteral feeding
Description: Enteral nutrition is caloric intake through the gastrointestinal (GI) tract via food consumed through the mouth or a feeding tube delivering nutrition directly to the stomach or small intestines. The PN dose will be written for each 24-hr period taking into account calories provided from any enteral feedings.